J.P. Morgan Private Wealth Advisors’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $679K | Sell |
3,463
-938
| -21% | -$184K | ﹤0.01% | 1118 |
|
|
2023
Q2 | $925K | Sell |
4,401
-148,463
| -97% | -$31.2M | ﹤0.01% | 786 |
|
|
2023
Q1 | $30.9M | Buy |
152,864
+31,725
| +26% | +$6.4M | 0.07% | 253 |
|
|
2022
Q4 | $26.4M | Sell |
121,139
-36,136
| -23% | -$7.87M | 0.06% | 272 |
|
|
2022
Q3 | $31M | Sell |
157,275
-5,673
| -3% | -$1.12M | 0.08% | 220 |
|
|
2022
Q2 | $34.9M | Buy |
162,948
+6,671
| +4% | +$1.43M | 0.09% | 208 |
|
|
2022
Q1 | $44.4M | Buy |
156,277
+152,262
| +3,792% | +$43.2M | 0.1% | 207 |
|
|
2021
Q4 | $1.51M | Buy |
4,015
+395
| +11% | +$149K | ﹤0.01% | 1040 |
|
|
2021
Q3 | $1.49M | Buy |
3,620
+20
| +0.6% | +$8.25K | ﹤0.01% | 1025 |
|
|
2021
Q2 | $1.33M | Buy |
3,600
+1,219
| +51% | +$451K | ﹤0.01% | 1054 |
|
|
2021
Q1 | $690K | Sell |
2,381
-11
| -0.5% | -$3.19K | ﹤0.01% | 1203 |
|
|
2020
Q4 | $598K | Buy |
2,392
+181
| +8% | +$45.3K | ﹤0.01% | 1219 |
|
|
2020
Q3 | $501K | Buy |
2,211
+608
| +38% | +$138K | ﹤0.01% | 1151 |
|
|
2020
Q2 | $279K | Buy |
+1,603
| New | +$279K | ﹤0.01% | 1339 |
|
|
2017
Q3 | – | Sell |
-2,226
| Closed | -$225K | – | 1249 |
|
|
2017
Q2 | $225K | Buy |
+2,226
| New | +$225K | ﹤0.01% | 1113 |
|